Ignite Creation Date:
2024-07-17 @ 10:48 AM
Last Modification Date:
2024-10-26 @ 3:33 PM
Study NCT ID:
NCT06480097
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
2024-06-28
First Post:
2024-06-04
Brief Title:
Bidirectional Cohort Study on Improvement of Quality of Life in Patients After Coronary Intervention With Kuanxiong Aerosol
Sponsor:
Nanfang Hospital Southern Medical University
Organization:
Nanfang Hospital Southern Medical University
Study Overview
Official Title:
Bidirectional Cohort Study on Improvement of Quality of Life in Patients After Coronary Intervention With Kuanxiong Aerosol
Status:
ENROLLING_BY_INVITATION
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this observational study is to compare in patients with Angina Pectoris after PCI for Coronary Heart Disease The main questions it aims to answer are
To evaluate the effect of Kuanxiong Aerosol on the quality of life of patients with angina pectoris after PCI for Coronary Heart Disease
To evaluate the effect of Kuanxiong Aerosol on relieving angina pectoris and improving cardiac function
The comparison group will received routine treatment The experimental group will received sublingual spray of Kuanxiong Aerosol on the basis of routine treatmenttwo sprays per timethree times a day for a continuous month After 1 month of treatment the quality of life the improvement of cardiac function and the relief of angina pectoris were compared between the two groups Researchers will compare two groups to see if Kuanxiong Aerosol can improve the quality of life cardiac function and reduce the frequency and duration of angina pectoris in patients with angina pectoris after PCI
To evaluate the effect of Kuanxiong Aerosol on the quality of life of patients with angina pectoris after PCI for Coronary Heart Disease
To evaluate the effect of Kuanxiong Aerosol on relieving angina pectoris and improving cardiac function
The comparison group will received routine treatment The experimental group will received sublingual spray of Kuanxiong Aerosol on the basis of routine treatmenttwo sprays per timethree times a day for a continuous month After 1 month of treatment the quality of life the improvement of cardiac function and the relief of angina pectoris were compared between the two groups Researchers will compare two groups to see if Kuanxiong Aerosol can improve the quality of life cardiac function and reduce the frequency and duration of angina pectoris in patients with angina pectoris after PCI
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: